These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8139917)

  • 1. Transposase A binding sites in the attachment sites of bacteriophage Mu that are essential for the activity of the enhancer and A binding sites that promote transposition towards Fpro-lac.
    van Drunen CM; Mientjes E; van Zuylen O; van de Putte P; Goosen N
    Nucleic Acids Res; 1994 Mar; 22(5):773-9. PubMed ID: 8139917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the A protein-binding sites in the in vitro transposition of mu DNA. A complex circuit of interactions involving the mu ends and the transpositional enhancer.
    Allison RG; Chaconas G
    J Biol Chem; 1992 Oct; 267(28):19963-70. PubMed ID: 1328189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-protein cooperativity in the assembly and stabilization of mu strand transfer complex. Relevance of DNA phasing and att site cleavage.
    Namgoong SY; Jayaram M; Kim K; Harshey RM
    J Mol Biol; 1994 May; 238(4):514-27. PubMed ID: 8176742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The wing of the enhancer-binding domain of Mu phage transposase is flexible and is essential for efficient transposition.
    Clubb RT; Mizuuchi M; Huth JR; Omichinski JG; Savilahti H; Mizuuchi K; Clore GM; Gronenborn AM
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1146-50. PubMed ID: 8577730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bacteriophage Mu transposition by Mu repressor and Fis.
    van Drunen CM; van Zuylen C; Mientjes EJ; Goosen N; van de Putte P
    Mol Microbiol; 1993 Oct; 10(2):293-8. PubMed ID: 7934820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Mu transposition requires interaction of transposase with a DNA sequence at the Mu operator: implications for regulation.
    Mizuuchi M; Mizuuchi K
    Cell; 1989 Jul; 58(2):399-408. PubMed ID: 2546681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational isomerization in phage Mu transpososome assembly: effects of the transpositional enhancer and of MuB.
    Mizuuchi M; Mizuuchi K
    EMBO J; 2001 Dec; 20(23):6927-35. PubMed ID: 11726528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer-independent variants of phage Mu transposase: enhancer-specific stimulation of catalytic activity by a partner transposase.
    Yang JY; Jayaram M; Harshey RM
    Genes Dev; 1995 Oct; 9(20):2545-55. PubMed ID: 7590234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNase protection analysis of the stable synaptic complexes involved in Mu transposition.
    Mizuuchi M; Baker TA; Mizuuchi K
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9031-5. PubMed ID: 1656459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-protein complexes during attachment-site synapsis in Mu DNA transposition.
    Kuo CF; Zou AH; Jayaram M; Getzoff E; Harshey R
    EMBO J; 1991 Jun; 10(6):1585-91. PubMed ID: 1851088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of distinct domains in Mu transposase with Mu DNA ends and an internal transpositional enhancer.
    Leung PC; Teplow DB; Harshey RM
    Nature; 1989 Apr; 338(6217):656-8. PubMed ID: 2539564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subsequence-specific DNA-binding domain resides in the 13 kDa amino terminus of the bacteriophage Mu transposase protein.
    Tolias PP; DuBow MS
    J Mol Recognit; 1989 Apr; 1(4):172-8. PubMed ID: 2561072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cis-acting DNA sequences required in vivo for bacteriophage Mu helper-mediated transposition and packaging.
    Harel J; Duplessis L; Kahn JS; DuBow MS
    Arch Microbiol; 1990; 154(1):67-72. PubMed ID: 2168695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the Mu A protein-mediated strand cleavage reaction by the Mu B protein, and the requirement of DNA nicking for stable type 1 transpososome formation. In vitro transposition characteristics of mini-Mu plasmids carrying terminal base pair mutations.
    Surette MG; Harkness T; Chaconas G
    J Biol Chem; 1991 Feb; 266(5):3118-24. PubMed ID: 1847140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mu transpositional enhancer can function in trans: requirement of the enhancer for synapsis but not strand cleavage.
    Surette MG; Chaconas G
    Cell; 1992 Mar; 68(6):1101-8. PubMed ID: 1312394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the transposase with the ends of Mu: formation of specific nucleoprotein structures and non-cooperative binding of the transposase to its binding sites.
    Groenen MA; Vollering M; Krijgsman P; van Drunen K; van de Putte P
    Nucleic Acids Res; 1987 Nov; 15(21):8831-44. PubMed ID: 2825121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transposase contacts with mu DNA ends.
    Zou AH; Leung PC; Harshey RM
    J Biol Chem; 1991 Oct; 266(30):20476-82. PubMed ID: 1657926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criss-crossed interactions between the enhancer and the att sites of phage Mu during DNA transposition.
    Jiang H; Yang JY; Harshey RM
    EMBO J; 1999 Jul; 18(13):3845-55. PubMed ID: 10393199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel DNA binding and nuclease activity in domain III of Mu transposase: evidence for a catalytic region involved in donor cleavage.
    Wu Z; Chaconas G
    EMBO J; 1995 Aug; 14(15):3835-43. PubMed ID: 7641701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functionally important sites in the bacteriophage Mu transposase protein.
    Ulycznyj PI; Forghani F; DuBow MS
    Mol Gen Genet; 1994 Feb; 242(3):272-9. PubMed ID: 8107674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.